Laurie J. Hall Trustee’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-110
| Closed | -$78K | – | 211 |
|
2024
Q4 | $78K | Hold |
110
| – | – | 0.03% | 166 |
|
2024
Q3 | $116K | Buy |
+110
| New | +$116K | 0.04% | 148 |
|
2024
Q2 | – | Sell |
-110
| Closed | -$106K | – | 252 |
|
2024
Q1 | $106K | Hold |
110
| – | – | 0.04% | 138 |
|
2023
Q4 | $97K | Hold |
110
| – | – | 0.04% | 141 |
|
2023
Q3 | $91K | Hold |
110
| – | – | 0.04% | 142 |
|
2023
Q2 | $79K | Hold |
110
| – | – | 0.03% | 149 |
|
2023
Q1 | $90K | Sell |
110
-15
| -12% | -$12.3K | 0.04% | 143 |
|
2022
Q4 | $90K | Sell |
125
-10
| -7% | -$7.2K | 0.04% | 142 |
|
2022
Q3 | $93K | Sell |
135
-20
| -13% | -$13.8K | 0.05% | 132 |
|
2022
Q2 | $92K | Hold |
155
| – | – | 0.04% | 139 |
|
2022
Q1 | $108K | Buy |
155
+5
| +3% | +$3.48K | 0.04% | 139 |
|
2021
Q4 | $95K | Hold |
150
| – | – | 0.03% | 153 |
|
2021
Q3 | $91K | Sell |
150
-30
| -17% | -$18.2K | 0.04% | 155 |
|
2021
Q2 | $101K | Hold |
180
| – | – | 0.04% | 148 |
|
2021
Q1 | $85K | Hold |
180
| – | – | 0.03% | 164 |
|
2020
Q4 | $87K | Hold |
180
| – | – | 0.04% | 159 |
|
2020
Q3 | $101K | Buy |
+180
| New | +$101K | 0.05% | 138 |
|
2019
Q4 | $56K | Hold |
150
| – | – | 0.03% | 175 |
|
2019
Q3 | $42K | Hold |
150
| – | – | 0.02% | 188 |
|
2019
Q2 | $47K | Hold |
150
| – | – | 0.02% | 181 |
|
2019
Q1 | $62K | Hold |
150
| – | – | 0.03% | 169 |
|
2018
Q4 | $62K | Sell |
150
-10
| -6% | -$4.13K | 0.03% | 164 |
|
2018
Q3 | $65K | Hold |
160
| – | – | 0.03% | 179 |
|
2018
Q2 | $55K | Hold |
160
| – | – | 0.03% | 188 |
|
2018
Q1 | $55K | Hold |
160
| – | – | 0.03% | 176 |
|
2017
Q4 | $60K | Sell |
160
-20
| -11% | -$7.5K | 0.03% | 177 |
|
2017
Q3 | $80.5K | Hold |
180
| – | – | 0.05% | 134 |
|
2017
Q2 | $88.4K | Hold |
180
| – | – | 0.06% | 131 |
|
2017
Q1 | $67.9K | Hold |
180
| – | – | 0.04% | 142 |
|
2016
Q4 | $65K | Buy |
+180
| New | +$65K | 0.04% | 143 |
|
2016
Q2 | $68K | Buy |
180
+90
| +100% | +$34K | 0.04% | 142 |
|
2016
Q1 | $36K | Buy |
+90
| New | +$36K | 0.02% | 161 |
|